| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/10/2004 | US20040108608 Method for stabilizing active components using polyol/polymer microcapsule, and cosmetic composition containing the microcapsule |
| 06/10/2004 | US20040108333 Platen pump |
| 06/10/2004 | CA2547531A1 Buoyant polymer particles for delivery of therapeutic agents to the central nervous system |
| 06/10/2004 | CA2518906A1 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof |
| 06/10/2004 | CA2509429A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 06/10/2004 | CA2507685A1 Process for manufacturing sustained release microbeads containing venlafaxine hci |
| 06/10/2004 | CA2507606A1 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna) |
| 06/10/2004 | CA2507551A1 An allergen dosage form |
| 06/10/2004 | CA2507356A1 High concentration formulations of opioids and opioid derivatives |
| 06/10/2004 | CA2507316A1 Liposomal glucocorticoids |
| 06/10/2004 | CA2507263A1 Liposomal formulations |
| 06/10/2004 | CA2507158A1 Treatment of headache with antipsychotics delivered by inhalation |
| 06/10/2004 | CA2506985A1 Preparation of polyphosphazene microspheres |
| 06/10/2004 | CA2506977A1 Method for modifying microparticles and device for modigying microparticles |
| 06/10/2004 | CA2506888A1 Selective cyclooxygenase-2 inhibitor patch |
| 06/10/2004 | CA2506749A1 Method of drug loading in liposomes by gradient |
| 06/10/2004 | CA2506746A1 Method of drug loading in liposomes by gradient |
| 06/10/2004 | CA2506628A1 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib, valdecoxib and benzopyran derivatives |
| 06/10/2004 | CA2506037A1 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | CA2504488A1 Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| 06/10/2004 | CA2501287A1 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib and valdecoxib |
| 06/10/2004 | CA2500535A1 Crystallization method and apparatus using an impinging plate assembly |
| 06/10/2004 | CA2485562A1 Appetite suppressant toothpaste |
| 06/09/2004 | EP1426401A1 Water-based emulgator wax gels |
| 06/09/2004 | EP1426361A1 Novel composition containing a bi-cyclic compound and a glyceride |
| 06/09/2004 | EP1426100A1 Stabilisation of aromatic moieties by aromatic polymers |
| 06/09/2004 | EP1426058A2 Liquid interferon-beta formulations |
| 06/09/2004 | EP1426053A1 Use of amphiphilic lipids for reducing tumor metastasis |
| 06/09/2004 | EP1426049A1 Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease |
| 06/09/2004 | EP1426045A1 Seamless filled capsules |
| 06/09/2004 | EP1426044A1 Use of esters of L-carnitine or alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/09/2004 | EP1426043A1 Effervescent pharmaceutical compositions for non conventional suspensions |
| 06/09/2004 | EP1426042A1 Surface treatment composition for soft substrates |
| 06/09/2004 | EP1426024A1 Plaster like chip systems for thermodynamic control of topical dermal and transdermal systems |
| 06/09/2004 | EP1426021A1 Implantable system with drug eluting cells for on-demand local drug delivery |
| 06/09/2004 | EP1425381A2 Emu-based formulations for wound treatment related application information |
| 06/09/2004 | EP1425310A2 Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof |
| 06/09/2004 | EP1425306A2 Nanoparticles comprising biologically active tnf which is immobilised on the same |
| 06/09/2004 | EP1425295A1 Modified peptides and their use for the treatment of autoimmune diseases |
| 06/09/2004 | EP1425112A1 Nanogels and their production using liposomes as reactors |
| 06/09/2004 | EP1425075A1 Azeotrope-like compositions of pentafluorobutane |
| 06/09/2004 | EP1425068A1 Systemical administration of some oxazolidinones, e.g. linezolid, for the treatment of ocular infections |
| 06/09/2004 | EP1425044A1 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 06/09/2004 | EP1425033A2 Use of hcg and lh in controlled ovarian hyperstimulation |
| 06/09/2004 | EP1425032A2 USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
| 06/09/2004 | EP1425021A1 Physiological method of improving vision |
| 06/09/2004 | EP1425019A1 Pharmaceutical composition |
| 06/09/2004 | EP1425005A1 Pharmaceutical compostion comprising lumiracoxib |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424997A1 Amino acid modulated extended release dosage form |
| 06/09/2004 | EP1424996A1 Method for the production of inhalation powders |
| 06/09/2004 | EP1424995A1 A bio-security system |
| 06/09/2004 | EP1424994A1 Preparation of sustained release pharmaceutical composition |
| 06/09/2004 | EP1424973A1 Disposal system for transdermal dosage form |
| 06/09/2004 | EP1424957A2 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/09/2004 | EP1424898A1 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 06/09/2004 | EP1424889A2 Method for treating lung cancers |
| 06/09/2004 | EP1337322B1 Method and device for producing lipid vesicles |
| 06/09/2004 | EP1165052B1 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining the same |
| 06/09/2004 | EP1143937B1 Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| 06/09/2004 | EP1043978B1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 06/09/2004 | EP1005339A4 Carotenoid formulation |
| 06/09/2004 | EP0835101B1 Method of producing sustained-release preparation |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | EP0748225B1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION |
| 06/09/2004 | DE20220902U1 Neuer Filmüberzug New film coating |
| 06/09/2004 | DE10255415A1 Dermale Applikation von Flupirtin Dermal application of flupirtine |
| 06/09/2004 | DE10255387A1 Neue Tiotropium-haltige Pulverformulierung für die Inhalation New tiotropium containing powder formulation for inhalation |
| 06/09/2004 | DE10255106A1 Liposomale Glucocorticoide Liposomal glucocorticoids |
| 06/09/2004 | DE10254636A1 Verfahren zum Modifizieren von Mikropartikeln sowie Vorrichtung zum Modifizieren von Mikropartikeln A method for modifying microparticles and apparatus for modifying microparticles |
| 06/09/2004 | DE10250944B3 Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase Using a stylus for the application of nursing or agents in the nose |
| 06/09/2004 | CN1503808A Purification method of hydroxypropylmethyl cellulose phthalate |
| 06/09/2004 | CN1503675A Telithromycin suspension with a masked taste |
| 06/09/2004 | CN1503670A Gastric acid secretion inhibiting composition |
| 06/09/2004 | CN1503664A Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 06/09/2004 | CN1503663A Film coating |
| 06/09/2004 | CN1503662A Pharmaceutical preparation |
| 06/09/2004 | CN1503661A Control of process humidify to produce large porous particles |
| 06/09/2004 | CN1503658A Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 06/09/2004 | CN1503633A Ingestible compositions contaiing odoriferous oil |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502373A Pressure-sensitive adhesive sheet for medical use and process for producing the same |
| 06/09/2004 | CN1502369A Bioadhesive pharmaceutical compositions based on non-steroidal anti-inflammatory drugs |
| 06/09/2004 | CN1502367A Immunoprophyaxis nose drops and preparation process thereof |
| 06/09/2004 | CN1502356A Blood pressure reducing health care incense and preparation method thereof |
| 06/09/2004 | CN1502354A Medicinal composition for preventing mycotic infection of AIDS patient and use thereof |
| 06/09/2004 | CN1502353A Compound chuanxiong and angelica total extract and preparation, use thereof |
| 06/09/2004 | CN1502341A Process for preparing novel traditional Chinese medicine-compound salvia dispersion tablet |
| 06/09/2004 | CN1502340A Process for prepaing ginkgo leaf dispersion tablet |
| 06/09/2004 | CN1502338A Process for preparing red active nano elementary selengelatin microcapsule |
| 06/09/2004 | CN1502337A Oral medicine for treating cardio-cerebral vascular disease and preparation process thereof |
| 06/09/2004 | CN1502334A Medicinal composition containing Adefovirdipivoxil |
| 06/09/2004 | CN1502333A Slow released table of captopril |
| 06/09/2004 | CN1502332A Process for preparing taxol self-emulsified solid nano granule-injection taxol of anti-cancer medicine |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1502328A Lamiophlomis rotate dispersion table preparation process |
| 06/09/2004 | CN1502327A Nano traditional Chinese medicinal health care beverage |
| 06/09/2004 | CN1502326A Rectal suppository |
| 06/09/2004 | CN1502325A Ascorbic acid aqueous solution and preparation process thereof |
| 06/09/2004 | CN1502322A Pharmaceutical dosage form and method of making |